Morning Industry Symposium: Practice-changing new perspectives on genomic profiling in the management of HR+, HER2- Early Breast Cancer
Supported by Genomic Health

Friday, October 12, 2018
Breakfast will be served prior to the session

 Chairpersons Bruce Mann, Australia    ­                                                                                                                                                          Hall A
Elgene Lim, Australia
07:15 – 07:20 Introduction
Elgene Lim, Australia
07:20 – 07:50 Level 1 Evidence on the Oncotype DX Breast Recurrence Score® Assay and Implications for Clinical Practice
Virginia Kaklamani, USA
07:50 – 08:25 Panel Discussion/Case Studies

Bruce Mann, Australia
Elgene Lim,  Australia

Virginia Kaklamani, USA
Richard de Boer, Australia
Cindy Mak, Australia